# Oramed Pharmaceuticals Inc.: Form SCHEDULE 13D, filed May 1, 2025

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: SCHEDULE 13D
- Filed: 2025-05-01
- Accepted by EDGAR: May 1, 2025, 13:59 ET
- Period: not reported
- Accession: 0001213900-25-038294
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390025038294/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390025038294/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390025038294/xslSCHEDULE_13D_X01/primary_doc.xml

Filed May 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-038294. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.